Breakthrough AI system may improve treatment of debilitating diseases
Join the Clinical Committee as a Co-Opted Member

Update from Ferring Pharmaceuticals regarding Desmopressin

18 Sep 2023

Ferring Pharmaceuticals have provided updated information regarding the future supply of DesmoSpray® nasal spray, Octim® nasal spray solution and DDAVP® (Desmopressin) intranasal solution

Ferring Pharmaceuticals will discontinue DDAVP Intranasal solution (Nasal Drops) 0.1mg/ml. Key information from the update:

  1. Desmopressin spray will be available next year once they've fixed their packaging and assembly
  2. Desmopressin nasal drops going to be discontinued
  3. Desmopressin tablets still available.


For more information, you can read the update in full.

Any questions please email clinical@endocrinology.org

Share this story

Top stories

Study using twins sees cardiovascular improvements with vegan diet
07 Dec 2023

Menarche at early age linked to increased diabetes risk
07 Dec 2023

In utero exposure to Covid-19 associated with preterm birth
07 Dec 2023

Type 2 diabetes risk may be reduced with fast walking
01 Dec 2023

Pomegranate consumption linked to prevention of metabolic disorders
01 Dec 2023

Most read